Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy

被引:65
|
作者
Gramatges, Maria M. [1 ]
Bertuch, Alison A. [1 ]
机构
[1] Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX 77030 USA
关键词
BONE-MARROW FAILURE; PRIMITIVE HEMATOPOIETIC-CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; MAINTENANCE COMPONENT 1; REVERSE-TRANSCRIPTASE; HUMAN CST; CEREBELLAR HYPOPLASIA; GENOMIC INSTABILITY; DUPLEX REPLICATION; END-PROTECTION;
D O I
10.1016/j.trsl.2013.05.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Telomeres are DNA-protein structures that form a protective cap on chromosome ends. As such, they prevent the natural ends of linear chromosomes from being subjected to DNA repair activities that would result in telomere fusion, degradation, or recombination. Both the DNA and protein components of the telomere are required for this essential function, because insufficient telomeric DNA length, loss of the terminal telomeric DNA structure, or deficiency of key telomere-associated factors may elicit a DNA damage response and result in cellular senescence or apoptosis. In the setting of failed checkpoint mechanisms, such DNA-protein defects can also lead to genomic instability through telomere fusions or recombination. Thus, as shown in both model systems and in humans, defects in telomere biology are implicated in cellular and organismal aging as well as in tumorigenesis. Bone marrow failure and malignancy are 2 life-threatening disease manifestations in the inherited telomere biology disorder dyskeratosis congenita. We provide an overview of basic telomere structure and maintenance. We outline the telomere biology defects observed in dyskeratosis congenita, focusing on recent discoveries in this field. Last, we review the evidence of how telomere biology may impact sporadic aplastic anemia and the risk for various cancers.
引用
收藏
页码:353 / 363
页数:11
相关论文
共 50 条
  • [1] Dyskeratosis congenita: short telomeres are not the rule
    Touzot, Fabien
    Le Guen, Tangui
    de Villartay, Jean-Pierre
    Revy, Patrick
    M S-MEDECINE SCIENCES, 2012, 28 (6-7): : 618 - 624
  • [2] Long tails, short telomeres: Dyskeratosis congenita
    Tummala, Hemanth
    Walne, Amanda J.
    ONCOTARGET, 2015, 6 (16) : 13856 - 13857
  • [3] Telomeres in dyskeratosis congenita
    Shay, JW
    Wright, WE
    NATURE GENETICS, 2004, 36 (05) : 437 - 438
  • [4] Telomeres in dyskeratosis congenita
    Jerry W Shay
    Woodring E Wright
    Nature Genetics, 2004, 36 : 437 - 438
  • [5] Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita
    Al-Rahawan, MM
    Giri, N
    Alter, BP
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (03) : 275 - 276
  • [6] Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita
    Mohamad M. Al-Rahawan
    Neelam Giri
    Blanche P. Alter
    International Journal of Hematology, 2006, 83 : 275 - 276
  • [7] Dysfunctional telomeres and dyskeratosis congenita
    Bessler, Monica
    Du, Hong-Yan
    Gu, Baiwei
    Mason, Philip J.
    HAEMATOLOGICA, 2007, 92 (08) : 1009 - 1012
  • [8] Accelerated shortening of long telomeres and accumulation of short telomeres in dyskeratosis congenita.
    Bessler, M
    Bouharich, R
    Kulkarni, S
    Freeman, S
    Du, HY
    Mason, PJ
    Londono-Vallejo, A
    Goldman, F
    BLOOD, 2005, 106 (11) : 307A - 307A
  • [9] RESPONSE TO ANDROGENS IN THE CONSTITUTIONAL APLASTIC-ANEMIA OF DYSKERATOSIS CONGENITA (DC)
    SMITH, CM
    RAMSAY, NKC
    BRANDA, R
    NESBIT, ME
    KRIVIT, W
    PEDIATRIC RESEARCH, 1979, 13 (04) : 441 - 441
  • [10] DYSKERATOSIS CONGENITA - RELATIONSHIP TO POIKILODERMA ATROPHICANS VASCULARE AND TO APLASTIC ANEMIA OF FANCONI
    COLE, HN
    COLE, HN
    LASCHEID, WP
    ARCHIVES OF DERMATOLOGY, 1957, 76 (06) : 712 - 719